Evidence Based Medicine presented by InpharmD™

Aug 28 2024 78 ep. 7 mins 19
Evidence Based Medicine presented by InpharmD™ Podcast artwork

We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.

  Health & Fitness
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Ketamine for Sickle Cell Disease

Aug 28 2024 13 mins  
InpharmD's EBM podcast focuses on commonly asked drug information questions and the associated literature. This episode focuses on the use of ketamine for Sickle Cell Disease.

Tirzepatide for Sleep Apnea

Jul 26 2024 11 mins  
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess tirzepatide for obstructive sleep apnea and analyze the SURMOUNT-OSA clinical trials.

Excoriation Disorder

May 28 2024 10 mins  
InpharmD's EBM podcast focuses on commonly asked drug information (DI) questions and the associated literature. Everyday, our queue gets tons of questions asked by health care providers all around the country. For this episode, we assess treatment options for excoriation disorder.

Phenytoin for Tacrolimus Toxicity

Apr 25 2024 14 mins  
InpharmD's EBM podcast focuses on commonly asked DI questions. Every day, our queue gets tons of new questions asked from providers all around the country. Today's podcast focuses on the use of phenytoin to treat tacrolimus toxicity.

Atypical Antipsychotics and QT–prolongation

Feb 26 2024 11 mins  
InpharmD's EBM podcast focuses on commonly asked drug information questions. Every day, our queue gets tons of new questions asked from providers all around the country. One question that’s been garnering a lot of views from our users right now is which atypical antipsychotics are associated with the lowest and highest risk of QT prolongation.

Apixaban in Peripheral Artery Disease

Nov 29 2023 10 mins  
Join InpharmD as we discuss the role of apixaban in peripheral artery disease.

Safety and Efficacy of RSV Vaccines

Sep 27 2023 9 mins  
Join InpharmD as we discuss the safety and efficacy of two FDA-approved RSV vaccines, Arexvy and Abrysvo.

Safety and Efficacy of Rezafungin

Jul 20 2023 9 mins  
Join us as we discuss the data surrounding newly approved antifungal agent, rezafungin. Interested in learning more? Join our CE on rezafungin on July 27th at 12:00 PM EST - open to all pharmacists!

Perioperative Duloxetine During Orthopedic Surgery for Pain Reduction

Jun 13 2023 8 mins  
Join InpharmD as we discuss the data on perioperative duloxetine (Cymbalta) during orthopedic surgery for pain reduction. Interested in the full data response? Read here!

Lecanemab in the treatment of Alzheimer’s Dementia

Apr 17 2023 9 mins  
Every month, InpharmD creates a continuing-education (CE) class on the most commonly asked drug information question and the related evidence. Our podcast offers a sneak peak into our CE as we briefly discuss the topic. Episode-2 looks at the safety and efficacy of lecanemab in the treatment of Alzheimer’s dementia.